Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Journal Home
Refine listing

Refine listing

Access:
Publication date:

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Send to Kindle
  • Send to Dropbox
  • Send to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

Volume 206 - February 2015

Contents

Page 1 of 10

Other

  • Editorial Board
  • Published online by Cambridge University Press: 16 April 2018, p. A9
    • Article
    • Access
    • PDF
    • Export citation
  • Editorial Board
  • Published online by Cambridge University Press: 16 April 2018, p. A13
    • Article
    • Access
    • PDF
    • Export citation
  • Editorial board
  • Published online by Cambridge University Press: 16 April 2018, p. A5
    • Article
    • Access
    • PDF
    • Export citation
  • Editorial board
  • Published online by Cambridge University Press: 16 April 2018, p. A1
    • Article
    • Access
    • PDF
    • Export citation
  • Editorial Board
  • Published online by Cambridge University Press: 16 April 2018, p. A17
    • Article
    • Access
    • PDF
    • Export citation
  • Editorial Board
  • Published online by Cambridge University Press: 31 May 2018, p. A21
    • Article
    • Access
    • PDF
    • Export citation
  • Highlights of this issue
  • Sukhwinder S. Shergill
  • Published online by Cambridge University Press: 02 January 2018, p. A19
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • Highlights of this issue
  • Kimberlie Dean
  • Published online by Cambridge University Press: 02 January 2018, p. A15
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • Highlights of this issue
  • Kimberlie Dean
  • Published online by Cambridge University Press: 02 January 2018, p. A7
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • Highlights of this issue
  • Kimberlie Dean
  • Published online by Cambridge University Press: 02 January 2018, p. A23
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • Highlights of this issue
  • Sukhwinder S. Shergill
  • Published online by Cambridge University Press: 02 January 2018, p. A11
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • Highlights of this issue
  • Sukhwinder S. Shergill
  • Published online by Cambridge University Press: 02 January 2018, p. A3
    • Article
    • Access
    • PDF
    • HTML
    • Export citation

Editorials

  • Danger ahead: Challenges in undergraduate psychiatry teaching and implications for community psychiatry
  • Reem Abed, Andrew Teodorczuk
  • Published online by Cambridge University Press: 02 January 2018, pp. 89-90
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • View abstract

    This editorial discusses current challenges faced by educators in undergraduate psychiatry in a community setting. It explores day-to-day difficulties faced by clinical educators and also considers the changing landscape of community services and how this might have an impact on learning opportunities. We call for efforts to improve undergraduate teaching in community psychiatry.

Editorial

  • Diagnostic neglect: The potential impact of losing a separate axis for personality disorder
  • Giles Newton-Howes, Roger Mulder, Peter Tyrer
  • Published online by Cambridge University Press: 02 January 2018, pp. 355-356
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • View abstract

    Both major classifications in psychiatry have now moved away from the multi-axial nosological model. This is clinically understandable as the specific categorical diagnoses, other than borderline personality disorder and personality disorder ‘NOS' (not otherwise specified) were so seldom used and empirical evidence would not support the polythetic categorical system. As a consequence, those with personality disorders, frequently referred to as Axis II disorders, now have to compete with all other mental disorders for clinical attention.

  • The role of social media in reducing stigma and discrimination
  • Victoria Betton, Rohan Borschmann, Mary Docherty, Stephen Coleman, Mark Brown, Claire Henderson
  • Published online by Cambridge University Press: 02 January 2018, pp. 443-444
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • View abstract

    This editorial explores the implications of social media practices whereby people with mental health problems share their experiences in online public spaces and challenge mental health stigma. Social media enable individuals to bring personal experience into the public domain with the potential to affect public attitudes and mainstream media. We draw tentative conclusions regarding the use of social media by campaigning organisations.

Editorials

  • An integrated biopsychosocial model of childhood maltreatment and psychosis
  • Victoria Barker, Andrew Gumley, Matthias Schwannauer, Stephen M. Lawrie
  • Published online by Cambridge University Press: 02 January 2018, pp. 177-180
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • View abstract

    There is now a well-established link between childhood maltreatment and psychosis. It is, however, unclear what the mechanisms are by which this occurs. Here, we propose a pathway linking the experience of childhood maltreatment with biological changes in the brain and suggest a psychological intervention to ameliorate its effects.

  • Can psychedelic compounds play a part in drug dependence therapy?
  • Ben Sessa, Matthew W. Johnson
  • Published online by Cambridge University Press: 02 January 2018, pp. 1-3
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • View abstract

    After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research this area.

Editorial

  • Technological innovations in mental healthcare: harnessing the digital revolution
  • Chris Hollis, Richard Morriss, Jennifer Martin, Sarah Amani, Rebecca Cotton, Mike Denis, Shôn Lewis
  • Published online by Cambridge University Press: 02 January 2018, pp. 263-265
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • View abstract

    Digital technology has the potential to transform mental healthcare by connecting patients, services and health data in new ways. Digital online and mobile applications can offer patients greater access to information and services and enhance clinical management and early intervention through access to real-time patient data. However, substantial gaps exist in the evidence base underlying these technologies. Greater patient and clinician involvement is needed to evaluate digital technologies and ensure they target unmet needs, maintain public trust and improve clinical outcomes.

Editorials

  • You're not welcome in here – poems by doctors
  • Hinesh Topiwala
  • Published online by Cambridge University Press: 02 January 2018, p. 180
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • Making a medicine out of MDMA
  • Ben Sessa, David Nutt
  • Published online by Cambridge University Press: 02 January 2018, pp. 4-6
    • Article
    • Access
    • PDF
    • HTML
    • Export citation
  • View abstract

    From its first use 3,4,-methylenedioxymethamphetamine (MDMA) has been recognised as a drug with therapeutic potential. Research on its clinical utility stopped when it entered the recreational drug scene but has slowly resurrected in the past decade. Currently there is enough evidence for MDMA to be removed from its Schedule 1 status of ‘no medical use’ and moved into Schedule 2 (alongside other misused but useful medicines such as heroin and amphetamine). Such a regulatory move would liberate its use as a medicine for patients experiencing severe mental illnesses such as treatment-resistant post-traumatic stress disorder.

Page 1 of 10